Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02890251
Other study ID # PSS2016/PREMAVISION-HASCOET/VS
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2016
Est. completion date August 31, 2016

Study information

Verified date February 2023
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose is to describe the level of visual maturation of premature newborns at term equivalent age. The secondary purpose is to determine factors associated to an altered level of visual maturation, through an exploratory approach.


Recruitment information / eligibility

Status Completed
Enrollment 69
Est. completion date August 31, 2016
Est. primary completion date June 30, 2016
Accepts healthy volunteers No
Gender All
Age group 6 Weeks to 10 Weeks
Eligibility Inclusion Criteria: - Infants born before 33 weeks of amenorrhea and hospitalized at CHRU Nancy Exclusion Criteria: - Parental opposition - Ocular malformation - Face malformation - Cranial stenosis - Chromosomal abnormality

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

References & Publications (1)

Wirth M, Naud A, Schmitt E, Clerc-Urmes I, Hascoet JM. Visual Maturation at Term Equivalent Age in Very Premature Infants According to Factors Influencing Its Development. Front Physiol. 2018 Nov 20;9:1649. doi: 10.3389/fphys.2018.01649. eCollection 2018. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of Visual Acuity by Baby Vision Cards Baby Vision cards are the French equivalent of Teller Cards - The measurement will be done at the term equivalent age : at the inclusion Baseline
Secondary Control of the Retina by Retinal Camera Use of Retcam to diagnose Retinopathy of Prematurity - The measurement will be done at the term equivalent age : at the inclusion Baseline
Secondary Measurement of cycloplegic refraction by mydriaticum 0.5% The measurement will be done at the term equivalent age : at the inclusion Baseline
Secondary Presence, absence of light reflex by clinical evaluation The measurement will be done at the term equivalent age : at the inclusion Baseline
Secondary Presence, absence or abnormality of visual fixation by clinical observation The measurement will be done at the term equivalent age : at the inclusion Baseline
Secondary Analysis of visual cortex with MRI Determinants of indices of cerebral volume in former very premature infants and their relation to visual maturation. The measurement will be done at the term equivalent age : at the inclusion Baseline
See also
  Status Clinical Trial Phase
Completed NCT04251338 - Delayed Visual Maturation: Outcome and Predictive Factors